James Kelly is a seasoned sell-side equity research analyst with over 13 years of experience in analyzing large and mid-sized pharmaceutical companies. Kelly studied MBA at Columbia University - Columbia Business School and BS at Lehigh University, equipping him with a strong educational background for his career. Kelly has held various high-level positions, including Director of Research and Associate Director of Research at SVB Securities, Vice President - Equity Research at Credit Suisse First Boston, Vice President - Global Investment Research at Goldman Sachs, and Associate at Lehman Brothers. He is currently Equity Research Management at SVB Securities, where he is leveraging his expertise to drive growth and enable teams to connect insights that lead to distinctive investment ideas. With his exceptional analytical and leadership skills, Kelly has built a reputation as an expert in analyzing pharmaceuticals, equity research management, and operations.